Salicylic Peel 25%

Clinical Protocols

Personalised strategies for different therapeutic objectives
Salicylic Peel 25% may be integrated into different aesthetic medicine programmes whenever there is an appropriate clinical indication and the patient has been correctly selected.
There is no single protocol suitable for every case. Planning should be adapted to the biological characteristics of the skin, the degree of sebaceous activity, the phototype, the condition of the skin barrier, the established therapeutic objectives and the clinical progression observed between sessions.
Due to its higher concentration, each procedure should carefully individualise the treatment area, the amount applied, the number of layers where appropriate, the contact time and the recovery intervals.
The protocols presented below constitute general guidance intended to facilitate therapeutic planning and should always be applied according to professional judgement and the official TherapDerma technical instructions.
________________________________________
SEBUM REGULATION PROTOCOL
Objective
To promote the progressive control of excess oiliness and improve the balance of oily skin through higher-intensity superficial exfoliation with keratolytic, purifying and sebum-regulating action.
It may be considered when there is
✔ oily skin;
✔ seborrhoeic skin;
✔ excessive skin shine;
✔ increased sebaceous production;
✔ enlarged or clogged pores;
✔ congested skin;
✔ insufficient response to lower-intensity superficial protocols, where there is a clinical indication.
Clinical objectives
• Promote the balance of sebaceous secretion.
• Progressively reduce surface shine.
• Purify the pilosebaceous environment.
• Improve the overall appearance of oily skin.
• Promote a more even appearance.
• Progressively optimise Skin Quality.
Continuation of treatment should be established according to the observed clinical progression, always reassessing tolerance, recovery of the skin barrier and the objectives achieved.
________________________________________
PORE PURIFICATION PROTOCOL
Objective
To promote the progressive removal of corneocytes, sebum, keratinous material and impurities accumulated within the pilosebaceous environment, contributing to visibly cleaner and less congested skin.
It may be considered when there is
✔ clogged pores;
✔ enlarged pores;
✔ open comedones;
✔ closed comedones;
✔ blackheads;
✔ uneven texture;
✔ superficial sebum accumulation;
✔ congested skin.
Clinical objectives
• Promote more intensive pore purification.
• Reduce follicular congestion.
• Improve the appearance of comedones.
• Visually refine skin texture.
• Progressively reduce pore visibility.
• Progressively optimise Skin Quality.
Progression should be reassessed before modifying the contact time, number of layers, frequency or intensity of the procedure.
________________________________________
PROTOCOL FOR ACNE-PRONE SKIN
Objective
To integrate Salicylic Peel 25% into a professional strategy aimed at progressively improving the appearance of acne-prone skin through exfoliating, keratolytic, purifying and sebum-regulating action of greater superficial intensity.
It may be considered when there is
✔ appropriately selected acne vulgaris;
✔ comedonal tendency;
✔ recurrent imperfections;
✔ excess sebum;
✔ clogged pores;
✔ uneven texture;
✔ oily skin with superficial congestion;
✔ superficial post-inflammatory marks.
Clinical objectives
• Promote a less congested pilosebaceous environment.
• Progressively improve the appearance of imperfections.
• Reduce the accumulation of sebum and keratin.
• Promote the reduction of comedones.
• Improve the appearance of superficial post-inflammatory marks.
• Promote cleaner and more balanced skin.
This protocol should be adapted to the type of acne, the degree of inflammation, the phototype, the medication used and individual tolerance.
Moderate or severe inflammatory forms should be assessed beforehand by a medical professional.
________________________________________
PROTOCOL FOR COMEDONES AND BLACKHEADS
Objective
To promote progressive pore decongestion by reducing the accumulation of keratin, sebum and superficial impurities.
It may be considered when there is
✔ blackheads;
✔ microcomedones;
✔ closed comedones;
✔ clogged pores;
✔ congested skin;
✔ uneven texture;
✔ superficial corneous accumulation.
Clinical objectives
• Promote progressive pore decongestion.
• Improve the appearance of blackheads.
• Reduce superficial keratin accumulation.
• Refine skin texture.
• Promote visibly cleaner skin.
• Support professional oily-skin control programmes.
Where professional extractions are incorporated, they should only be performed when clinically indicated and while respecting skin integrity.
________________________________________
PORE REFINEMENT PROTOCOL
Objective
To progressively improve the appearance of enlarged or visible pores through oil regulation, follicular purification and superficial epidermal renewal.
It may be considered when there is
✔ enlarged pores;
✔ visible pores;
✔ excess sebum;
✔ uneven texture;
✔ congested skin;
✔ comedones;
✔ loss of superficial uniformity.
Clinical objectives
• Visually reduce the appearance of pores.
• Promote a more refined texture.
• Improve sebaceous balance.
• Reduce follicular congestion.
• Progressively optimise Skin Quality.
The anatomical size of a pore cannot be permanently changed. The objective is to reduce its visibility through sebum control, follicular decongestion and the progressive improvement of skin texture.
________________________________________
TEXTURE IMPROVEMENT PROTOCOL
Objective
To progressively optimise the skin microrelief through higher-intensity selective superficial exfoliation.
It may be considered when there is
✔ uneven texture;
✔ a rough surface;
✔ corneous accumulation;
✔ visible pores;
✔ comedones;
✔ oily or congested skin;
✔ superficial irregularities associated with photodamage;
✔ superficial post-acne scars.
Clinical objectives
• Progressively refine texture.
• Promote a more even surface.
• Reduce the sensation of roughness.
• Visually smooth the skin microrelief.
• Improve the visual clarity of the skin.
• Progressively optimise Skin Quality.
Each session should be reassessed before continuing with the protocol.
________________________________________
PROTOCOL FOR SUPERFICIAL POST-ACNE SCARS
Objective
To promote the progressive improvement of the appearance of superficial post-acne scars through carefully controlled chemical exfoliation programmes.
It may be considered when there is
✔ superficial post-acne scars;
✔ mild irregularities of the skin microrelief;
✔ residual superficial marks;
✔ post-inflammatory tone irregularities;
✔ uneven texture;
✔ loss of visual uniformity.
Clinical objectives
• Promote progressive epidermal renewal.
• Improve the appearance of the superficial microrelief.
• Progressively refine texture.
• Optimise the appearance of superficial scars.
• Promote more even skin.
• Integrate treatment into Skin Quality programmes.
Deep, depressed or complex scars require specific assessment and may require complementary procedures.
________________________________________
PROTOCOL FOR SUPERFICIAL POST-INFLAMMATORY HYPERPIGMENTATION
Objective
To promote the progressive improvement of superficial tone irregularities that may persist following inflammatory processes or acne lesions.
It may be considered when there is
✔ superficial post-inflammatory hyperpigmentation;
✔ dark post-acne marks;
✔ visibly uneven tone;
✔ altered superficial texture;
✔ oily skin prone to new imperfections;
✔ loss of visual uniformity.
Clinical objectives
• Promote greater visual tone uniformity.
• Progressively improve the appearance of post-inflammatory marks.
• Promote controlled epidermal renewal.
• Optimise the visual clarity of the skin.
• Promote visibly more homogeneous skin.
• Integrate treatment into Skin Quality programmes.
Planning should always consider the phototype, pigmentary predisposition, control of inflammation and strict adherence to photoprotection.
________________________________________
PROTOCOL FOR SUPERFICIAL FRECKLES AND LENTIGINES
Objective
To progressively improve the appearance of correctly diagnosed superficial pigmentary irregularities through controlled epidermal renewal.
It may be considered when there is
✔ freckles;
✔ benign superficial lentigines;
✔ uneven tone associated with sun exposure;
✔ superficial photodamage;
✔ loss of radiance and visual uniformity.
Clinical objectives
• Promote greater visual tone uniformity.
• Progressively improve the appearance of superficial pigmentation.
• Promote renewal of the epidermal surface.
• Promote visibly more radiant skin.
• Progressively optimise Skin Quality.
Before the procedure, the benign nature of the lesions should be confirmed. Any atypical, changing or undiagnosed pigmented lesion should be medically assessed.
________________________________________
PROTOCOL FOR SUPERFICIAL PHOTODAMAGE
Objective
To promote progressive epidermal renewal and improve the appearance of superficial alterations associated with cumulative sun exposure.
It may be considered when there is
✔ uneven texture associated with photodamage;
✔ visibly uneven tone;
✔ freckles or superficial lentigines;
✔ a rough skin surface;
✔ loss of radiance;
✔ visible signs of superficial photoageing.
Clinical objectives
• Promote epidermal renewal.
• Progressively improve texture.
• Promote greater visual tone uniformity.
• Optimise the appearance of superficial lentigines.
• Promote visibly more renewed skin.
• Progressively improve Skin Quality.
Daily photoprotection and prevention of further intense exposure are essential components of the protocol.
________________________________________
PROTOCOL FOR STABILISED SEBORRHOEIC DERMATITIS
Objective
To promote the controlled removal of superficial scales and contribute to the progressive balance of the sebum-rich environment in appropriately selected patients.
It may be considered when there is
✔ a confirmed diagnosis of seborrhoeic dermatitis;
✔ clinically stabilised disease;
✔ superficial scaling without active inflammation;
✔ excess oiliness;
✔ uneven texture associated with scale accumulation.
Clinical objectives
• Promote the progressive removal of superficial scales.
• Improve skin texture.
• Contribute to the balance of the sebaceous environment.
• Promote visibly more even skin.
• Progressively optimise comfort and Skin Quality.
The procedure should not be performed where there is active inflammation, intense erythema, fissures, erosions, significant itching or impairment of the skin barrier.
________________________________________
PROTOCOL FOR MODERATE ACTINIC KERATOSIS
Objective
To integrate Salicylic Peel 25% into a professional strategy intended for correctly diagnosed lesions associated with chronic sun damage.
It may only be considered when there is
✔ a confirmed medical diagnosis of moderate actinic keratosis;
✔ a favourable assessment by a legally authorised healthcare professional;
✔ absence of suspicious clinical signs;
✔ a specific indication within a therapeutic plan;
✔ the possibility of clinical follow-up.
Clinical objectives
• Promote controlled exfoliation of the keratotic surface.
• Progressively improve superficial texture.
• Integrate the procedure into an individualised medical strategy.
• Facilitate structured monitoring of progression.
This protocol should be performed exclusively by legally authorised healthcare professionals and within the applicable professional and regulatory framework.
Salicylic Peel 25% should not be applied to undiagnosed, atypical or suspicious lesions.
________________________________________
PROTOCOL FOR MALE SKIN
Objective
To adapt the sebum-regulating, keratolytic and purifying action of Salicylic Peel 25% to the specific characteristics of male skin.
It may be considered when there is
✔ high sebaceous production;
✔ enlarged pores;
✔ blackheads;
✔ uneven texture;
✔ pseudofolliculitis;
✔ ingrown hairs;
✔ shaving-related imperfections;
✔ a thickened stratum corneum.
Clinical objectives
• Promote the balance of sebaceous secretion.
• Improve the appearance of ingrown hairs.
• Reduce follicular congestion.
• Progressively refine texture.
• Promote cleaner and more even skin.
Planning should be adapted to shaving frequency and the clinical condition of the skin. The procedure should not be performed immediately after aggressive shaving or on irritated skin.
________________________________________
PROTOCOL FOR BODY ACNE
Objective
To integrate Salicylic Peel 25% into protocols designed to progressively improve the appearance of body acne, follicular congestion and residual superficial marks.
Areas that may be considered
✔ back;
✔ shoulders;
✔ chest;
✔ décolletage in carefully selected cases;
✔ other areas with high sebaceous activity.
It may be considered when there is
✔ appropriately selected body acne;
✔ comedones;
✔ appropriately assessed superficial folliculitis;
✔ excess oiliness;
✔ clogged pores;
✔ uneven texture;
✔ superficial post-inflammatory hyperpigmentation;
✔ superficial post-acne scars.
Clinical objectives
• Promote the balance of sebaceous activity.
• Promote follicular purification.
• Progressively improve the appearance of body acne.
• Reduce superficial congestion.
• Improve the appearance of superficial marks and scars.
• Optimise body texture and Skin Quality.
The treatment area, amount of product, contact time and frequency should be individualised. Due to the larger body surface, it may be appropriate to treat areas sequentially.
________________________________________
SKIN QUALITY PROTOCOL FOR OILY AND PHOTOAGED SKIN
Objective
To integrate Salicylic Peel 25% into a comprehensive programme intended to progressively optimise the Skin Quality of oily, acne-prone, photoaged skin or skin with superficial tone irregularities.
Areas of action
✔ oiliness;
✔ pores;
✔ comedones;
✔ texture;
✔ superficial post-acne scars;
✔ post-inflammatory hyperpigmentation;
✔ superficial photodamage;
✔ visual uniformity;
✔ skin clarity;
✔ Skin Quality.
Therapeutic integration
Where there is an appropriate clinical indication, Salicylic Peel 25% may be incorporated together with:
✔ personalised mesotherapy;
✔ sebum-regulating protocols;
✔ depigmenting protocols;
✔ PDRN;
✔ soothing and regenerating active ingredients;
✔ blue LED therapy;
✔ red LED therapy;
✔ compatible medical-aesthetic technologies;
✔ professional home-care cosmetics.
The combination of procedures should be carefully planned, always respecting recovery of the skin barrier and the physiological intervals between treatments.
________________________________________
THERAPDERMA COMBINED PROTOCOLS™
Integration into a comprehensive therapeutic strategy
Where there is an appropriate clinical indication, Salicylic Peel 25% may be incorporated into multidisciplinary programmes intended to progressively improve oily, acne-prone, photoaged skin or skin with superficial tone irregularities through a comprehensive approach.
Options that may be combined sequentially include:
✔ personalised mesotherapy;
✔ sebum-regulating protocols;
✔ depigmenting protocols;
✔ PDRN;
✔ soothing and regenerating active ingredients;
✔ blue LED therapy;
✔ red LED therapy;
✔ biostimulation;
✔ compatible medical-aesthetic technologies;
✔ professional home-care cosmetics;
✔ skin-barrier recovery programmes.
The selection of each procedure should always correspond to a specific clinical objective and the individual progression of each patient.
________________________________________
EXAMPLE OF THERAPDERMA INTEGRATION™
Advanced Purifying & Renewal Protocol
Objective
To promote progressively less oily, less congested, more even and visibly renewed skin through a sequential professional strategy.
Phase 1 — Exfoliation, purification and renewal
Salicylic Peel 25%
Objectives:
✔ remove accumulated corneocytes;
✔ promote more intensive pore purification;
✔ progressively regulate excess sebum;
✔ improve texture and superficial tone irregularities;
✔ prepare the skin for subsequent phases.
Phase 2 — Regulation, regeneration and skin comfort
Mesotherapy, PDRN or professional cosmetics selected according to the diagnosis.
Objectives:
✔ complement the sebum-regulating or regenerating action;
✔ promote skin comfort;
✔ support recovery of the skin barrier;
✔ progressively improve the overall appearance of the skin.
Phase 3 — Photobiomodulation
LED therapy selected according to the clinical objectives.
Objectives:
✔ support protocols for acne-prone skin;
✔ promote comfort and recovery;
✔ complement the overall therapeutic strategy.
The sequence and intervals between procedures should be individualised.
________________________________________
THERAPDERMA CLINICAL LADDER™
Individualised treatment selection
The TherapDerma Clinical Ladder™ facilitates selection of the most appropriate strategy according to the clinical needs and progression of each patient.
Initial BHA Level
Salicylic Peel 15%
It may be considered when the objective is to:
✔ progressively regulate excess sebum;
✔ improve the appearance of pores;
✔ promote superficial decongestion;
✔ cosmetically treat comedones;
✔ support protocols for acne-prone skin;
✔ develop periodic maintenance programmes;
✔ progressively optimise Skin Quality.
Advanced BHA Level
Salicylic Peel 25%
It may be considered when the objective is to:
✔ perform higher-intensity superficial exfoliation;
✔ promote more intensive purification of the pilosebaceous environment;
✔ address enlarged pores and more marked congestion;
✔ improve the appearance of superficial post-acne scars;
✔ treat correctly diagnosed superficial pigmentary irregularities;
✔ promote the renewal of photoaged skin;
✔ progressively optimise texture, tone and Skin Quality.
Therapeutic progression should always correspond to the patient’s clinical progression.
Progression from Salicylic Peel 15% to Salicylic Peel 25% should never be automatic. It should be justified according to the diagnosis, therapeutic objectives, recovery of the skin barrier, tolerance and the clinical response obtained.
________________________________________
PROTOCOL PERSONALISATION
Each patient presents different biological and clinical characteristics.
For this reason, therapeutic planning should be individualised during every session.
Personalisation may involve adapting:
✔ the extent of the treatment area;
✔ the contact time;
✔ the amount of product;
✔ the number of layers where included in the protocol;
✔ the treatment sequence;
✔ the frequency of sessions;
✔ the combination with other procedures;
✔ home care;
✔ the photoprotection plan;
✔ recovery periods.
Protocol flexibility makes it possible to optimise the therapeutic response while always respecting skin physiology.
________________________________________
CRITERIA FOR MODIFYING OR DISCONTINUING THE PROGRAMME
During follow-up, the therapeutic strategy may be modified whenever clinical progression indicates that this is advisable.
Situations that may justify adaptation include:
✔ slower recovery than expected;
✔ prolonged skin sensitivity;
✔ persistent erythema;
✔ excessive peeling;
✔ impairment of the skin barrier;
✔ development of post-inflammatory hyperpigmentation;
✔ insufficient therapeutic response;
✔ increased inflammation;
✔ changes in medication or home-care routine;
✔ recent sun exposure;
✔ development of new clinical circumstances;
✔ achievement of the therapeutic objectives.
Following the corresponding reassessment, the professional may:
• maintain the protocol;
• reduce the intensity;
• reduce the contact time;
• reduce the number of layers;
• increase the interval between sessions;
• modify the home-care routine;
• reinforce photoprotection;
• integrate complementary procedures;
• temporarily prioritise recovery of the skin barrier;
• replace Salicylic Peel 25% with a lower concentration;
• temporarily or permanently discontinue treatment.
Modifying a protocol when required by the clinical situation is a professional decision based on safety, individualisation and scientific evidence.
________________________________________
THERAPDERMA CONCLUSION
Clinical protocols provide guidance for structuring treatment, but never replace professional judgement or the individual assessment of each patient.
Salicylic Peel 25% makes it possible to develop personalised higher-intensity superficial exfoliation programmes aimed at controlling oiliness, purifying the pilosebaceous environment, improving the appearance of comedones and enlarged pores, refining texture and promoting greater visual tone uniformity.
It may also be integrated into protocols intended for photodamage, post-inflammatory hyperpigmentation, freckles, lentigines and superficial post-acne scars where there is an appropriate clinical indication.
As part of the TherapDerma Clinical Ecosystem™, each protocol should evolve through continuous reassessment, therapeutic personalisation and the rational integration of complementary procedures, allowing the development of progressive, reproducible treatments based on scientific criteria.